. Author manuscript; available in PMC: 2011 Apr 18.

Published in final edited form as: J Clin Psychiatry. 2010 Aug 10;71(12):1673–1679. doi: 10.4088/JCP.09m05188blu

Table 4.

Adjusted models for the association between HT use after the inclusion and new-onset depressive symptoms after 4-year follow-up, among women without depression at baseline.

	HT use (n)	Depressive symptoms (%)	OR^a[95% CI]	p-value
HT use 4-year after the inclusion	Never (n=2037)	15.95	1.0
	Continuing (n=162)	17.90	1.34 [0.84–2.15]	0.22
	Discontinuing (early)^b (n=76)	30.30	2.63 [1.52–4.55]	0.0005

Adjusted for age, educational level, centre, widowhood, age at menopause, insomnia, disability, cognitive impairment, chronic health disorders and history of depression.

discontinuing between the inclusion and the first 2-year follow-up.

Abbreviation: HT = Hormonal Therapy.